What's New

SyncThink Releases Next Generation EYE-SYNC Concussion Solution

FDA-cleared eye tracking virtual reality device is comprehensive assessment for prominent clinic subtypes of concussion Boston, MA—June 26, 2017—SyncThink, world leader in neuro-technology with foundational intellectual property in eye tracking metrics and devices, announces today the next generation of its FDA Cleared EYE-SYNC technology. EYE-SYNC is an objective and comprehensive assessment tool to assess ocular-motor […]

Read article

This Local Company Wants to Revolutionize Concussion Diagnosis

Boston Magazine

Read article

Stanford football uses Virtual Reality headsets to help them diagnose concussions

Rule of Tree

Read article

Eye-Sync tracking technology helps diagnose concussions on the spot

Valley News Live

Read article

Eye-Sync Technology Helping Stanford Diagnose Concussions More Quickly

CBS Local Sports

Read article

Pulse@MassChallenge Spurs Deals in Digital Health Lab’s 1st Session

Xconomy  

Read article

Measuring Orientation: A New Approach to Concussion Screening and Treatment

Practical Neurology

Read article

Not just for gamers: How SyncThink uses VR to detect when athletes have concussions

BuiltinBoston  

Read article

Can Jam Ghajar and others change the way football tackles concussions?

San Francisco Business Journal

Read article

Virtual reality gets into the game against concussions

Boston Globe

Read article

The future of fighting sports concussions could be virtual reality

Salon

Read article

EYE-SYNC Device That Assesses Abnormal Eye Movement, a Common Deficit After Concussion, Gains FDA Clearance

New Fully Integrated Head-Mounted Eye Tracking Device for Rapid Assessment of Abnormal Eye Movement Officially Available From SyncThink BOSTON, MA–(Marketwired – March 22, 2016) – SyncThink, a world leader in neuro-technology with foundational intellectual property in eye tracking metrics and devices, announces today the FDA clearance for its first medical device — EYE-SYNC. The EYE-SYNC […]

Read article